Jury orders Pfizer to pay $38 million

By
December 24, 2008 06:34

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

A California jury has ordered drugmaker Pfizer Inc. to pay $38 million to a leading Bay Area medical research nonprofit for stealing trade secrets to develop a pain relief drug. A Santa Clara County Superior Court jury reached the verdict Monday in a 2004 lawsuit filed against Pfizer by the San Bruno-based nonprofit Ischemia Research and Education Foundation. The lawsuit said Pfizer in 2002 wanted to use the foundation's database for clinical trials on Bextra, a drug to treat acute pain chiefly caused by arthritis. The drug was eventually taken off the market over concerns it posed a heart risk.

Related Content

Rashida Tlaib on interview about Arab-Israeli Conflict (August 13, 2018).
August 17, 2018
J Street cancels endorsement from House candidate for 'one state solution'

By MICHAEL WILNER